Not Signed In - Genta Cites Publication Of Study Showing Improved Outcomes In CLL Patients Treated With Genasense(R) Plus Chemotherapy
Thu, 15 Feb 2007 08:00 AM EST
... Genta Incorporated (Nasdaq: GNTA) today announced the publication of findings from a Phase 3 trial of the Company's lead anticancer drug, Genasense(R) (oblimersen sodium) Injection, when used in combination with chemotherapy for treatment of patients with relapsed or refractory chronic lymphocytic leukemia (CLL). [click link for full article] ...
Related Topics
- Publications & Software
- Chemotherapy
- Online Publications
- Publication Request
- Vaccinations For HIV/AIDs Patients
- What Your Female Patients Want to Know About Bladder Control
- Fluorouracil
- Smoking Cessation and Continued Risk in Cancer Patients
- Publication Lists And Catalogs
- Laboratory Biosafety Publication
- Nausea And Vomiting
- Radiation Studies
- Pelvic Examination
- Aspirin, Butalbital, and Caffeine
- Chemical Agents
- PET Study
- Caregiving
- Chronic Lymphocytic Leukemia
- Leukemia, Chronic Lymphocytic
- Doxorubicin Liposomal Injection
email this page
print this page
bookmark this page
feedback on this page
